Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001615774-17-005426
Filing Date
2017-09-29
Accepted
2017-09-29 06:58:00
Documents
10
Period of Report
2017-09-28

Document Format Files

Seq Description Document Type Size
1 6-K s107627_6k.htm 6-K 15357
2 EXHIBIT 99.1 s107627_ex99-1.htm EX-99.1 1546508
3 EXHIBIT 99.2 s107627_ex99-2.htm EX-99.2 125993
4 EXHIBIT 99.3 s107627_ex99-3.htm EX-99.3 120205
5 GRAPHIC img004_v1.jpg GRAPHIC 52978
6 GRAPHIC img005_v1.jpg GRAPHIC 6323
7 GRAPHIC img006_v1.jpg GRAPHIC 3029
8 GRAPHIC img002_v1.jpg GRAPHIC 6288
9 GRAPHIC img003_v1.jpg GRAPHIC 78014
10 GRAPHIC img001_v1.jpg GRAPHIC 3272
  Complete submission text file 0001615774-17-005426.txt   2016338
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 171108958
SIC: 2834 Pharmaceutical Preparations